The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 19548059)

Published in Basic Res Cardiol on June 23, 2009

Authors

S Frantz1, A Adamek, D Fraccarollo, J Tillmanns, J D Widder, C Dienesch, A Schäfer, A Podolskaya, M Held, H Ruetten, G Ertl, J Bauersachs

Author Affiliations

1: Medizinische Klinik und Poliklinik I, Universitätsklinikum Würzburg, Josef-Schneider-Str. 2, 97080 Würzburg, Germany. Frantz_S@medizin.uni-wuerzburg.de

Articles by these authors

Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell (1994) 7.39

Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation (1993) 4.85

Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity (2000) 2.93

Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation (1997) 2.65

A novel pathway of DNA end-to-end joining. Cell (1990) 2.61

Oscillatory kinetics and spatio-temporal self-organization in reactions at solid surfaces. Science (1991) 2.12

Dobutamine-stress magnetic resonance microimaging in mice : acute changes of cardiac geometry and function in normal and failing murine hearts. Circ Res (2001) 2.08

Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol (1994) 2.06

Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications. J Intern Med (2013) 1.96

Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation (1999) 1.89

Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology (2001) 1.87

Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J (1999) 1.76

Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study. Gut (2007) 1.75

Expression of the Bacillus subtilis sacB gene leads to sucrose sensitivity in the gram-positive bacterium Corynebacterium glutamicum but not in Streptomyces lividans. J Bacteriol (1992) 1.68

Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J (1999) 1.65

Fast high-resolution magnetic resonance imaging demonstrates fractality of myocardial perfusion in microscopic dimensions. Circ Res (2001) 1.64

Mutational analysis of the SOX9 gene in campomelic dysplasia and autosomal sex reversal: lack of genotype/phenotype correlations. Hum Mol Genet (1997) 1.60

Low circulating androgens and mortality risk in heart failure. Heart (2009) 1.56

Ca2+-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress. Circ Res (1998) 1.50

Overexpression of the sarcolemmal calcium pump in the myocardium of transgenic rats. Circ Res (1998) 1.49

Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br J Pharmacol (1997) 1.48

Changes in myocardial oxygenation and perfusion under pharmacological stress with dipyridamole: assessment using T*2 and T1 measurements. Magn Reson Med (1999) 1.48

Anal endosonography and manometry: comparison in patients with defecation problems. Dis Colon Rectum (1997) 1.46

Studies on the orientation of brush-border membrane vesicles. Biochem J (1978) 1.46

Helicobacter pylori and acute bleeding peptic ulcer. Eur J Gastroenterol Hepatol (1995) 1.46

Accumulation of sulfoquinovosyl-1-O-dihydroxyacetone in a sulfolipid-deficient mutant of Rhodobacter sphaeroides inactivated in sqdC. Arch Biochem Biophys (1997) 1.44

Prevention of endothelial dysfunction in heart failure by vitamin E: attenuation of vascular superoxide anion formation and increase in soluble guanylyl cyclase expression. Cardiovasc Res (2001) 1.44

Interaction of hydrogen with RuO2(110) surfaces: activity differences between various oxygen species. J Phys Chem B (2006) 1.43

A transferable, beta-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells. J Physiol (1996) 1.42

[Morphologic studies of the placentas of HIV-positive mothers]. Pathologe (1988) 1.41

Comparison of anal sonography with conventional needle electromyography in the evaluation of anal sphincter defects. Am J Gastroenterol (1996) 1.40

LAV/HTLV-III in 20-week fetus. Lancet (1985) 1.40

Clubbing due to peripheral hypervascularization: recognition by contrast-enhanced, three-dimensional magnetic resonance angiography. Circulation (2001) 1.39

[Disseminated lymphangioleiomyomatosis]. Geburtshilfe Frauenheilkd (1992) 1.38

[Virus-specific antibody profile in various stages of HIV-1 infection. Western blot analysis of 170 patients]. Klin Wochenschr (1988) 1.38

Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. J Am Coll Cardiol (2001) 1.35

Serial cine-magnetic resonance imaging of left ventricular remodeling after myocardial infarction in rats. J Magn Reson Imaging (2001) 1.35

Spectroscopic evidence for the interaction of phalloidin with actin. FEBS Lett (1975) 1.28

Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension (1997) 1.26

Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction. Circulation (2001) 1.23

The effect of perfusion on T1 after slice-selective spin inversion in the isolated cardioplegic rat heart: measurement of a lower bound of intracapillary-extravascular water proton exchange rate. Magn Reson Med (1997) 1.20

Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol (2013) 1.20

Influence of mutation type and location on phenotype in 123 patients with Rett syndrome. Neuropediatrics (2002) 1.17

Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor. Circulation (1982) 1.17

Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C. Psychosomatics (2000) 1.16

IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer (1996) 1.16

Isometric contraction induces the Ca2+-independent activation of the endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (1999) 1.15

Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J (1984) 1.14

Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C. Aliment Pharmacol Ther (2002) 1.13

The cannabinoid receptor-1 antagonist rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker rats. Br J Pharmacol (2008) 1.13

Magnetization exchange in capillaries by microcirculation affects diffusion-controlled spin-relaxation: a model which describes the effect of perfusion on relaxation enhancement by intravascular contrast agents. Magn Reson Med (1996) 1.12

Expression of pyruvate kinase M2 in preneoplastic hepatic foci of N-nitrosomorpholine-treated rats. Virchows Arch (1999) 1.12

Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice. Proc Natl Acad Sci U S A (2001) 1.11

Isolation of insertion elements from gram-positive Brevibacterium, Corynebacterium and Rhodococcus strains using the Bacillus subtilis sacB gene as a positive selection marker. FEMS Microbiol Lett (1995) 1.11

Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: an independent predictor of mortality. Eur J Heart Fail (2008) 1.10

Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression. J Viral Hepat (2005) 1.07

Cardiac magnetic resonance imaging in small animal models of human heart failure. Med Image Anal (2003) 1.07

Sunny days, healthy ways: evaluation of a skin cancer prevention curriculum for elementary school-aged children. J Am Acad Dermatol (1996) 1.06

Downregulation of the Na(+)-creatine cotransporter in failing human myocardium and in experimental heart failure. Circulation (1999) 1.05

Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus. Br J Pharmacol (2007) 1.05

Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group. Transplant Proc (1998) 1.05

The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol (1995) 1.05

Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition. Dig Dis Sci (2001) 1.04

The staphylococcal phosphoenolpyruvate-dependent phosphotransferase system. Purification and characterisation of the galactoside-specific membrane-component enzyme II. Eur J Biochem (1981) 1.04

Myocardial perfusion and intracapillary blood volume in rats at rest and with coronary dilatation: MR imaging in vivo with use of a spin-labeling technique. Radiology (2000) 1.03

Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors. Am Heart J (2000) 1.02

On the effect of prostaglandins E2 and F2alpha on bronchial tonus in cats. Eur J Pharmacol (1974) 1.02

Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase. Br J Pharmacol (1999) 1.00

Theory of the BOLD effect in the capillary region: an analytical approach for the determination of T2 in the capillary network of myocardium. Magn Reson Med (1999) 1.00

Time course of cardiac structural, functional and electrical changes in asymptomatic patients after myocardial infarction: their inter-relation and prognostic impact. J Am Coll Cardiol (2001) 0.99

Low systemic exposure to tacrolimus correlates with acute rejection. Transplant Proc (1999) 0.99

Chronic phosphocreatine depletion by the creatine analogue beta-guanidinopropionate is associated with increased mortality and loss of ATP in rats after myocardial infarction. Circulation (2001) 0.99

Calcium-dependent and calcium-independent activation of the endothelial NO synthase. J Vasc Res (1997) 0.99

Integration of narrow-host-range vectors from Escherichia coli into the genomes of amino acid-producing corynebacteria after intergeneric conjugation. J Bacteriol (1996) 0.98

Purification and characterization of 2-hydroxybiphenyl 3-monooxygenase, a novel NADH-dependent, FAD-containing aromatic hydroxylase from Pseudomonas azelaica HBP1. J Biol Chem (1997) 0.98

Demonstration of HIV-1 infected cells in human placenta by in situ hybridisation and immunostaining. J Clin Pathol (1992) 0.98

Pharmacokinetics of tacrolimus: clinically relevant aspects. Transplant Proc (1999) 0.97

Effects of Boundaries on Pattern Formation: Catalytic Oxidation of CO on Platinum. Science (1994) 0.96

Gastric cancer and human leukocyte antigen: distinct DQ and DR alleles are associated with development of gastric cancer and infection by Helicobacter pylori. Cancer Res (2001) 0.96

Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients. Eur J Drug Metab Pharmacokinet (1999) 0.96

The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects. Drug Metab Dispos (1999) 0.96

Spatiotemporal addressing of surface activity. Science (2001) 0.95

Primary structure differences of human surfactant-associated proteins isolated from normal and proteinosis lung. Biochim Biophys Acta (1992) 0.95

Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy. J Investig Med (1997) 0.94

Hyperoxic ventilation at the critical haematocrit. Resuscitation (2003) 0.94

The role of the Corynebacterium glutamicum rel gene in (p)ppGpp metabolism. Microbiology (1998) 0.94

Identification, cloning and sequencing of the replication region of Lactococcus lactis ssp. lactis biovar. diacetylactis Bu2 citrate plasmid pSL2. FEMS Microbiol Lett (1991) 0.93

BOLD-MRI in ten patients with coronary artery disease: evidence for imaging of capillary recruitment in myocardium supplied by the stenotic artery. MAGMA (1999) 0.93

HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study. Eur J Clin Invest (2007) 0.93